| Product Code: ETC8537038 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Netherlands continues to be a key destination for drug-device combination products import shipments, with top exporters in 2024 being Germany, USA, Ireland, Belgium, and Italy. The market shows moderate concentration with a Herfindahl-Hirschman Index (HHI) in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 is robust at 5.02%, indicating sustained expansion in the market. Furthermore, the growth rate from 2023 to 2024 is a positive 0.84%, highlighting a steady upward trend in import shipments of these products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Drug-Device Combination Products Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Netherlands Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Netherlands Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Netherlands Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Netherlands Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Netherlands Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Netherlands Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring combined drug-device therapies |
4.2.2 Technological advancements in drug-device combination products |
4.2.3 Growing demand for personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-device combination products |
4.3.2 High development costs and lengthy approval processes |
4.3.3 Limited reimbursement policies for combination products |
5 Netherlands Drug-Device Combination Products Market Trends |
6 Netherlands Drug-Device Combination Products Market, By Types |
6.1 Netherlands Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Netherlands Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Netherlands Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Netherlands Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Netherlands Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Netherlands Drug-Device Combination Products Market Export to Major Countries |
7.2 Netherlands Drug-Device Combination Products Market Imports from Major Countries |
8 Netherlands Drug-Device Combination Products Market Key Performance Indicators |
8.1 Patient adherence rates to drug-device combination therapies |
8.2 Number of successful clinical trials for new combination products |
8.3 Adoption rate of innovative drug-device combination products |
8.4 Percentage of market share held by drug-device combination products in specific therapeutic areas |
9 Netherlands Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Netherlands Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Netherlands Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Netherlands Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Netherlands Drug-Device Combination Products Market - Competitive Landscape |
10.1 Netherlands Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Netherlands Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here